Skip to content
healthcare.dev

Praluent

NDC 61755-021, alirocumab, injection, solution, from Regeneron Pharmaceuticals, Inc..

Product NDC
61755-021
Status
Listed
Labeler
Regeneron Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125559
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61755-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALIROCUMAB150 mg/mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; PCSK9 Inhibitor [EPC]; PCSK9 Inhibitors [MoA]

Package NDCNDC-11Package
61755-021-01617550021011 SYRINGE, GLASS in 1 CARTON (61755-021-01) / 1 mL in 1 SYRINGE, GLASS
61755-021-02617550021022 SYRINGE, GLASS in 1 CARTON (61755-021-02) / 1 mL in 1 SYRINGE, GLASS
61755-021-04617550021041 SYRINGE, GLASS in 1 CARTON (61755-021-04) / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7bcfbac2-e8ac-4569-8edc-bcde3b1fd172
  • NADAC price for package 61755002102

    GET /v1/drugs/nadac/61755002102

Use it

Look up 61755-021 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61755-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61755-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.